Vipragen Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 87

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $423K

  • Investors
  • 4

Vipragen Biosciences General Information

Description

Operator of a pre-clinical contract research organization intended to cater to quality science and reliable data delivery. The company offers drug discovery services, safety studies in general and genetic toxicology, analytical services, drug testing laboratory services, and physicochemical testing, enabling businesses to accelerate their drug discovery and development processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Centre for Cellular and Molecular Platforms (C-CAMP)
  • GKVK Campus, Bellary Road
  • Bengaluru, Karnataka 560065
  • India
+91 098808
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Services
Media and Information Services (B2B)
Vertical(s)
Corporate Office
  • Centre for Cellular and Molecular Platforms (C-CAMP)
  • GKVK Campus, Bellary Road
  • Bengaluru, Karnataka 560065
  • India
+91 098808

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vipragen Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 22-Aug-2023 $423K Completed Generating Revenue
4. Later Stage VC 17-Oct-2019 Completed Generating Revenue
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator $471K Completed Startup
1. Angel (individual) 19-Mar-2018 $471K $471K Completed Startup
To view Vipragen Biosciences’s complete valuation and funding history, request access »

Vipragen Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Ordinary
Ordinary 608,052 $0.120945 $0.63 $0.63 1x $0.63 7.68%
Ordinary 2,682,680 $0.120945 $0.14 $0.14 1x $0.14 33.88%
To view Vipragen Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vipragen Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pre-clinical contract research organization intended to cater to quality science and reliable data deliver
Other Pharmaceuticals and Biotechnology
Bengaluru, India
87 As of 2026

Noida, India
 

Seraing, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vipragen Biosciences Competitors (2)

One of Vipragen Biosciences’s 2 competitors is Allele Life Sciences Private, a Corporation company based in Noida, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Allele Life Sciences Private Corporation Noida, India
Kaneka Eurogentec Formerly PE-Backed Seraing, Belgium
You’re viewing 2 of 2 competitors. Get the full list »

Vipragen Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vipragen Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Conscience Multi Family Office Family Office Minority
Karnataka Information Technology Venture Capital Funds Venture Capital Minority
Centre for Cellular And Molecular Platforms Accelerator/Incubator
Startup Karnataka Accelerator/Incubator
To view Vipragen Biosciences’s complete investors history, request access »

Vipragen Biosciences FAQs

  • When was Vipragen Biosciences founded?

    Vipragen Biosciences was founded in 2012.

  • Where is Vipragen Biosciences headquartered?

    Vipragen Biosciences is headquartered in Bengaluru, India.

  • What is the size of Vipragen Biosciences?

    Vipragen Biosciences has 87 total employees.

  • What industry is Vipragen Biosciences in?

    Vipragen Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Vipragen Biosciences a private or public company?

    Vipragen Biosciences is a Private company.

  • What is the current valuation of Vipragen Biosciences?

    The current valuation of Vipragen Biosciences is .

  • What is Vipragen Biosciences’s current revenue?

    The current revenue for Vipragen Biosciences is .

  • How much funding has Vipragen Biosciences raised over time?

    Vipragen Biosciences has raised $1.73M.

  • Who are Vipragen Biosciences’s investors?

    Conscience Multi Family Office, Karnataka Information Technology Venture Capital Funds, Centre for Cellular And Molecular Platforms, and Startup Karnataka have invested in Vipragen Biosciences.

  • Who are Vipragen Biosciences’s competitors?

    Allele Life Sciences Private and Kaneka Eurogentec are competitors of Vipragen Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process